TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jason Stout, MD
Duke University
Study Chair - Neil Schluger, MD
Columbia University
Study Chair - Susan Dorman, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Universitario Clementino Fraga Filho
Rio de Janeiro, Rio de Janeiro, Brazil
- University of Manitoba
Winnepeg, Manitoba, Canada
- Montreal Chest Institute Mcgill University
Montreal, Quebec, Canada
- Nelson R Mandela School of Medicine
Durban, KwaZulu-Natal, South Africa
- Agencia de Salut Publica
Barcelona, Spain
- Makerere University Medical School
Kampala, Uganda
- Central Arkansas Veterans Health System
Little Rock, Arkansas, United States
- la County/usc Medical Center
Los Angeles, California, United States
- University of Southern California Medical Center
Los Angeles, California, United States
- University of California at San Diego
San Diego, California, United States
- University of California, San Francincisco
San Francisco, California, United States
- Denver Department of Public Health and Hospitals
Denver, Colorado, United States
- Washington Dc Veterans Administration Medical Center
Washington D.C., District of Columbia, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Chicago Va Medical Center (lakeside)
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Hines Va Medical Center
Hines, Illinois, United States
- Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- New Jersey Medical School
Newark, New Jersey, United States
- Columbia University/presbyterian Medical Center
New York, New York, United States
- Harlem Hospital, Columbia University
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Nashville Va Medical Center
Nashville, Tennessee, United States
- Veterans Administration Tennessee Valley Health Care System
Nashville, Tennessee, United States
- University of North Texas Health Science Center
Fort Worth, Texas, United States
- Houston Veterans Administration Medical Center
Houston, Texas, United States
- Audi L. Murphy Va Hospital
San Antonio, Texas, United States
- Seattle King County Health Department
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 30 Jun 2013
- Completion
- 31 Dec 2013
- Last update posted
- 8 May 2014
- Registered enrollment
- 865
- Registry id
- NCT00694629
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.